| Business Name: |
Mcr Rheumatology |
| Contact Person: |
David Ryckman |
| Address: |
1350 Locust St # 300, Pittsburgh, Pennsylvania 15219 |
| Phone Number: |
(412) 232-5539 |
| Annual Revenue (USD): |
$100.000 to $499.999 |
| Founding Year: |
2005 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
621111 |
| Share This Business: |
|
| Related Businesses: |
Greenberg Karin DO - Pittsburgh, PA 15219
Michelle Jo Semins MD - Pittsburgh, PA 15219
Upmc - Pittsburgh, PA 15219
Specialists Inc - Pittsburgh, PA 15219
Calvelo Manuel G MD - Pittsburgh, PA 15219
Chaudry Mohammad I MD - Pittsburgh, PA 15219
Bharill Parth S MD - Pittsburgh, PA 15219
Carson Paul Allen MD - Pittsburgh, PA 15219
Barrette Roger R MD - Pittsburgh, PA 15219
Bursick Daniel MD - Pittsburgh, PA 15219
Altschuler Eric M MD - Pittsburgh, PA 15219
Chang Edward J MD - Pittsburgh, PA 15219
Love Your Face LLC - Pittsburgh, PA 15219
Hilal Elias Y MD - Pittsburgh, PA 15219
Oliva Lisa A DO - Pittsburgh, PA 15219
Boron Ronald L MD - Pittsburgh, PA 15219
Fatur Leo M MD - Pittsburgh, PA 15219
Department of Pediatrics - Pittsburgh, PA 15219
Six Cheryl K DO - Pittsburgh, PA 15219
Culig Carl A MD - Pittsburgh, PA 15219
|
The company Mcr Rheumatology provides B2C services in the form of Doctors from its single location in Pennsylvania.
1 to 4 employees work for Mcr Rheumatology, and the business now earns $100.000 to $499.999 per annum.
Mcr Rheumatology was launched in 2005 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 .
To contact Mcr Rheumatology, please call David Ryckman with the phone number (412) 232-5539 or visit its single location at 1350 Locust St # 300 in Pittsburgh, Pennsylvania 15219.
The location of the single location can also be found using the coordinates 40.436992,-79.98881.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.